A share price of Outset Medical Inc [OM] is currently trading at $0.61, up 7.02%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The OM shares have gain 12.13% over the last week, with a monthly amount glided 4.47%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Outset Medical Inc [NASDAQ: OM] stock has seen the most recent analyst activity on August 08, 2024, when RBC Capital Mkts downgraded its rating to a Sector Perform and also revised its price target to $3 from $6. Previously, RBC Capital Mkts upgraded its rating to Outperform on June 21, 2024, and elevated its price target to $6. On April 08, 2024, BTIG Research initiated with a Buy rating and assigned a price target of $6 on the stock. CL King upgraded its rating to a Buy but stick to its price target of $6 on April 05, 2024. RBC Capital Mkts downgraded its rating to a Sector Perform and reduced its price target to $6 on January 12, 2024. BofA Securities downgraded its rating to Underperform for this stock on October 13, 2023, and downed its price target to $3. In a note dated August 17, 2023, CL King initiated an Neutral rating.
Outset Medical Inc experienced fluctuations in its stock price throughout the past year between $0.44 and $6.37. Currently, Wall Street analysts expect the stock to reach $11 within the next 12 months. Outset Medical Inc [NASDAQ: OM] shares were valued at $0.61 at the most recent close of the market. An investor can expect a potential return of 1703.28% based on the average OM price forecast.
Analyzing the OM fundamentals
Trailing Twelve Months sales for Outset Medical Inc [NASDAQ:OM] were 116.42M which represents -24.01% decline. Gross Profit Margin for this corporation currently stands at 0.28% with Operating Profit Margin at -1.29%, Pretax Profit Margin comes in at -1.36%, and Net Profit Margin reading is -1.37%. To continue investigating profitability, this company’s Return on Assets is posted at -0.51, Equity is -1.46 and Total Capital is -0.56. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.9.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5678 points at the first support level, and at 0.5255 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6445, and for the 2nd resistance point, it is at 0.6789.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Outset Medical Inc [NASDAQ:OM] is 6.80. Also, the Quick Ratio is 5.38, while the Cash Ratio stands at 0.87. Considering the valuation of this stock, the price to sales ratio is 0.29, the price to book ratio is 0.46.
Transactions by insiders
Recent insider trading involved Trigg Leslie, Chair and CEO, that happened on Aug 15 ’24 when 5308.0 shares were sold. SVP Operations and R&D, Nash Marc completed a deal on Aug 15 ’24 to sell 1293.0 shares. Meanwhile, General Counsel Brottem John L. sold 3011.0 shares on Aug 15 ’24.
